Extracellular molecules in hematopoietic stem cell mobilisation.
Hematopoietic stem cells are a remarkable resource currently used for the life saving treatment, hematopoietic stem cell transplantation. Today, hematopoietic stem cells are primarily obtained from mobilized peripheral blood following treatment of the donor with the cytokine G-CSF, and in some settings, chemotherapy and/or the CXCR4 antagonist plerixafor. The collection of hematopoietic stem cells is contingent on adequate and timely mobilization of these cells into the peripheral blood. The use of healthy donors, particularly when unrelated to the patient, requires mobilization strategies be safe for the donor. While current mobilization strategies are largely successful, adequate mobilization fails to occur in a significant portion of donors. Understanding the mechanisms involved in the egress of stem cells from the bone marrow provides opportunities to further improve the process of collecting hematopoietic stem cells. Here, the role extracellular components of the blood and bone marrow in the mobilization process are discussed.
Centre for Cancer Research, Westmead Institute for Medical Research, University of Sydney, 176 Hawkesbury Rd, Westmead, Sydney, NSW, 2145, Australia. linda.bendall@sydney.edu.au.
Linda
L
Bendall
D000818:Animals; D018925:Chemokines / Q000737:chemistry / Q000494:pharmacology; D003165:Complement System Proteins / Q000494:pharmacology; D005109:Extracellular Matrix / Q000737:chemistry; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods*; D006801:Humans; D055153:Stem Cell Niche
D018925:Chemokines; D003165:Complement System Proteins
Chemokine; Hematopoietic stem cell; Matrix; Mobilization